iPLA ₂ β: A novel store-operated calcium entry modulator contributing to muscle dysfunction during denervation

Sarcopenia, the age-related loss of skeletal muscle mass and strength, is a major cause of frailty and disability, with neuromuscular denervation as a key contributor. Bioactive lipid mediators, including lipid hydroperoxides and oxylipins, contribute to denervation-induced muscle atrophy and dysfunction. Here, we identify calcium-independent phospholipase A 2 β (iPLA 2 β) as a novel regulator of store-operated calcium ion (Ca 2+ ) entry (SOCE), a critical process for maintaining Ca 2+ homeostasis via stromal interaction molecule 1 (STIM1) and Orai1 coupling in skeletal muscle. Using muscle-specific iPLA 2 β knockout (miPLA 2 βKO) mice, we show that iPLA 2 β interacts with STIM1-Orai1 coupling to modulate SOCE. Denervation elevates iPLA 2 β, hyperactivating SOCE and causing Ca 2+ overload through oxidative impairment of regulators such as SERCA. iPLA 2 β deletion normalizes SOCE, preserves Ca 2+ homeostasis, and protects against denervation-induced muscle mass (5%) and strength loss (50%). These findings reveal that iPLA 2 β may be a critical link between oxidative stress and Ca 2+ dysregulation and a promising target for mitigating muscle dysfunction during denervation.